Activation of Kras alone (K) or together with P53 loss (KP) in genetically engineered mouse models (GEMM) are able to initiate clonal outgrowth of lung adenocarcinoma in vivo (DuPage et al, 2009). This evidence concerns the gene KRAS and lung adenocarcinoma.